Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-02-28 @ 3:47 AM
Study NCT ID:
NCT03641794
Status:
UNKNOWN
Last Update Posted:
2019-08-01
First Post:
2018-08-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers
Sponsor:
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumors | View |
Keywords: